
Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in Massachusetts, and operates a lab in Bangalore in India.

Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in Massachusetts, and operates a lab in Bangalore in India.
What they do: Precision oncology diagnostics using a live tumor microenvironment platform and AI to predict treatment response
Headquarters / labs: Headquartered in the U.S.; lab/operations in Bengaluru (Bangalore), India
Founded: 2019
Sample scale: Reports having analyzed >23,000 human tumor samples
Employees: Approximately 45
Precision oncology; predicting individual tumor treatment response and enabling translational research for drug development
2019
Biotechnology
Crunchbase lists a Pre-Seed round with Techstars as lead investor; some public profiles obfuscate round amounts.
74631591
Aggregate total funding reported with date listed in company snapshot data.
“Accel; Alumni Ventures; Karnataka Information Technology Venture Capital Fund; Northpond Ventures; Peak XV Partners; RA Capital Management; Sands Capital Ventures; Tata Capital; Techstars”